Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith–Wiedemann Syndrome: Clinical Spectrum and Functional Characterization

Beckwith–Wiedemann syndrome (BWS) is an imprinting disorder associating macroglossia, abdominal wall defects, visceromegaly, and a high risk of childhood tumor. Molecular anomalies are mostly epigenetic; however, mutations of CDKN1C are implicated in 8% of cases, including both sporadic and familial forms. We aimed to describe the phenotype of BWS patients with CDKN1C mutations and develop a functional test for CDKN1C mutations. For each propositus, we sequenced the three exons and intron–exon boundaries of CDKN1C in patients presenting a BWS phenotype, including abdominal wall defects, without 11p15 methylation defects. We developed a functional test based on flow cytometry. We identified 37 mutations in 38 pedigrees (50 patients and seven fetuses). Analysis of parental samples when available showed that all mutations tested but one was inherited from the mother. The four missense mutations led to a less severe phenotype (lower frequency of exomphalos) than the other 33 mutations. The following four tumors occurred: one neuroblastoma, one ganglioneuroblastoma, one melanoma, and one acute lymphoid leukemia. Cases of BWS caused by CDKN1C mutations are not rare. CDKN1C sequencing should be performed for BWS patients presenting with abdominal wall defects or cleft palate without 11p15 methylation defects or body asymmetry, or in familial cases of BWS.

[1]  M. Cubellis,et al.  (Epi)genotype–phenotype correlations in Beckwith–Wiedemann syndrome , 2015, European Journal of Human Genetics.

[2]  P. Lapunzina,et al.  CDKN1C mutations: two sides of the same coin. , 2014, Trends in molecular medicine.

[3]  L. Pasquier,et al.  Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome. , 2014, Human molecular genetics.

[4]  Michael H. Guo,et al.  A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[5]  L. Tee,et al.  Methylation analysis and diagnostics of Beckwith-Wiedemann syndrome in 1,000 subjects , 2014, Clinical Epigenetics.

[6]  R. Weksberg,et al.  High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith–Wiedemann syndrome , 2014, Human Genetics.

[7]  M. Vazquez,et al.  Beckwith-Wiedemann Syndrome: Growth Pattern and Tumor Risk according to Molecular Mechanism, and Guidelines for Tumor Surveillance , 2013, Hormone Research in Paediatrics.

[8]  M. Nakanishi,et al.  Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome , 2013, PloS one.

[9]  A. Faussat,et al.  CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome , 2013, Journal of Medical Genetics.

[10]  O. Bruland,et al.  Evidence for anticipation in Beckwith–Wiedemann syndrome , 2013, European Journal of Human Genetics.

[11]  M. Cubellis,et al.  The molecular function and clinical phenotype of partial deletions of the IGF2/H19 imprinting control region depends on the spatial arrangement of the remaining CTCF-binding sites , 2012, Human molecular genetics.

[12]  Thomas Eggermann,et al.  Clinical significance of copy number variations in the 11p15.5 imprinting control regions: new cases and review of the literature , 2012, Journal of Medical Genetics.

[13]  R. Weksberg,et al.  Brain abnormalities in patients with Beckwith–Wiedemann syndrome , 2012, American journal of medical genetics. Part A.

[14]  S. Nelson,et al.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.

[15]  L. Faivre,et al.  New insights into the pathogenesis of beckwith–wiedemann and silver–russell syndromes: Contribution of small copy number variations to 11p15 imprinting defects , 2011, Human mutation.

[16]  S. Perrotta,et al.  p57Kip2 and Cancer: Time for a Critical Appraisal , 2011, Molecular Cancer Research.

[17]  Simon James Tunster,et al.  Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome , 2011, Disease Models & Mechanisms.

[18]  A. El-Osta,et al.  Epigenetic and genetic mechanisms of abnormal 11p15 genomic imprinting in Silver-Russell and Beckwith-Wiedemann syndromes. , 2011, Current medicinal chemistry.

[19]  C. Gicquel,et al.  Allele‐specific methylated multiplex real‐time quantitative PCR (ASMM RTQ‐PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell Silver and Beckwith Wiedemann syndromes , 2011, Human mutation.

[20]  I. Coupier,et al.  Acute lymphocytic leukaemia in a child with Beckwith-Wiedemann syndrome harbouring a CDKN1C mutation. , 2010, European journal of medical genetics.

[21]  J. Wesselink,et al.  CDKN1C (p57Kip2) analysis in Beckwith–Wiedemann syndrome (BWS) patients: Genotype–phenotype correlations, novel mutations, and polymorphisms , 2010, American journal of medical genetics. Part A.

[22]  R. Frydman,et al.  Beckwith–Wiedemann syndrome in association with posterior hypoplasia of the cerebellar vermis , 2009, Prenatal diagnosis.

[23]  P. Lapunzina,et al.  CDKN1C mutations in HELLP/preeclamptic mothers of Beckwith-Wiedemann Syndrome (BWS) patients. , 2009, Placenta.

[24]  E. Medrano,et al.  Different expression patterns of p27KIP1 and p57KIP2 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes , 2009, Journal of cutaneous pathology.

[25]  R. Weksberg,et al.  Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations. , 2001, Genomics.

[26]  W. Reik,et al.  Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation , 1999, Journal of medical genetics.

[27]  B. Tycko,et al.  Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. , 1997, American journal of human genetics.

[28]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[29]  M. Barbacid,et al.  Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.

[30]  Y. Fukushima,et al.  An imprinted gene p57KIP2 is mutated in Beckwith–Wiedemann syndrome , 1996, Nature Genetics.

[31]  Yusuke Nakamura,et al.  Characterization of the human p57KIP2 gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis , 1996, Human Genetics.

[32]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[33]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[34]  Cohen Mm.  Macroglossia, omphalocele, visceromegaly, cytomegaly of the adrenal cortex and neonatal hypoglycemia. , 1971 .

[35]  T. Mukai,et al.  Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome , 1999, Human Genetics.

[36]  M. Cohen.  Macroglossia, omphalocele, visceromegaly, cytomegaly of the adrenal cortex and neonatal hypoglycemia. , 1971, Birth defects original article series.